Lista de obras - Kenneth Chapman - Dominio Público Uruguay

A 21-year-old man with systemic-onset juvenile rheumatoid arthritis, cough and progressive dyspnea.

artículo científico publicado en 2010

A Step Forward in COPD Management ⬇️

artículo científico publicado el 1 de noviembre de 2012

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

artículo científico publicado en 2014

Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline ⬇️

artículo científico publicado el 1 de marzo de 2012

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease

artículo científico publicado en 2012

Asthma controller delay and recurrence risk after an emergency department visit or hospitalization

artículo científico publicado en 2012

Asthma that is unresponsive to usual care

artículo científico publicado en 2009

Bronchodilator responsiveness and reported respiratory symptoms in an adult population

artículo científico publicado en 2013

Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.

artículo científico publicado en 2011

Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD.

artículo científico publicado en 2012

Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study.

artículo científico publicado en 2011

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease ⬇️

artículo científico publicado el 5 de marzo de 2012

Current thinking and new paradigm for COPD.

artículo científico publicado en 2016

Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.

artículo científico publicado en 2011

Do we know the minimal clinically important difference (MCID) for COPD exacerbations?

artículo científico

Dynamic airway evaluation with volume CT: initial experience

artículo científico publicado en 2010

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial

scientific article published on 19 July 2020

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD

scientific article published on 21 November 2019

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.

artículo científico publicado en 2018

Exacerbations in non-COPD patients: truth or myth--authors' response

artículo científico publicado en 2014

Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction

artículo científico publicado en 2010

Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study

artículo científico publicado en 2011

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma

artículo científico publicado en 2009

Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario

artículo científico publicado en 2011

Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study

artículo científico publicado en 2010

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

scientific article published on 21 August 2013

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study

artículo científico publicado en 2010

Profile of eicosanoids in breath condensate in asthma and COPD

scholarly article by Leandro Genehr Fritscher et al published 27 March 2012 in Journal of Breath Research

Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testing

artículo científico publicado en 2014

Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor

artículo científico publicado en 2012

Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study

artículo científico publicado en 2019

SMART isn't

artículo científico publicado en 2010

Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study

artículo científico

Self-Management and Clinical Decision Support for Patients With Complex Chronic Conditions Through the Use of Smartphone-Based Telemonitoring: Randomized Controlled Trial Protocol.

artículo científico publicado en 2017

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal

scientific article published on 27 June 2010

The association between chronic exposure to traffic-related air pollution and ischemic heart disease

artículo científico publicado en 2012

The clinical impact of single inhaler therapy in asthma.

artículo científico

The effects of marijuana smoking on lung function in older people

scientific article published on 19 December 2019

The prevalence of asthma and atopy in schoolchildren from Porto Alegre, Brazil, has plateaued

artículo científico publicado en 2015

Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries

artículo científico publicado en 2013

What do we know about asthma triggers? a review of the literature

artículo científico

Lista de obras de Kenneth Chapman

A 21-year-old man with systemic-onset juvenile rheumatoid arthritis, cough and progressive dyspnea.

A Step Forward in COPD Management ⬇️

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

Alpha-1 Antitrypsin Deficiency Targeted Testing and Augmentation Therapy: A Canadian Thoracic Society Clinical Practice Guideline ⬇️

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease

Asthma controller delay and recurrence risk after an emergency department visit or hospitalization

Asthma that is unresponsive to usual care

Bronchodilator responsiveness and reported respiratory symptoms in an adult population

Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.

Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD.

Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study.

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease ⬇️

Current thinking and new paradigm for COPD.

Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD.

Do we know the minimal clinically important difference (MCID) for COPD exacerbations?

Dynamic airway evaluation with volume CT: initial experience

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study.

Exacerbations in non-COPD patients: truth or myth--authors' response

Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction

Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study

Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma

Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in Ontario

Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control study

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha₁-antitrypsin deficiency: a randomized study

Profile of eicosanoids in breath condensate in asthma and COPD

Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testing

Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor

Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study

SMART isn't

Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study

Self-Management and Clinical Decision Support for Patients With Complex Chronic Conditions Through the Use of Smartphone-Based Telemonitoring: Randomized Controlled Trial Protocol.

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal

The association between chronic exposure to traffic-related air pollution and ischemic heart disease

The clinical impact of single inhaler therapy in asthma.

The effects of marijuana smoking on lung function in older people

The prevalence of asthma and atopy in schoolchildren from Porto Alegre, Brazil, has plateaued

Types, frequency and impact of asthma triggers on patients' lives: a quantitative study in five European countries

What do we know about asthma triggers? a review of the literature